ArticleJournal of breast cancer2017

Development of a Nomogram to Predict N2 or N3 Stage in T1-2 Invasive Breast Cancer Patients with No Palpable Lymphadenopathy.

Isaac Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.